Jupiter Life Line Hospitals logo

Jupiter Life Line Hospitals financials and balance sheet

NSE: JLHLBSE: 543980Healthcare ServicesSmall Cap

Last close ₹244.00up ₹0.95 (0.39%)BSE ₹244.25

Share price at the NSE close on 23 Oct 2026. Previous close ₹243.05.

52-week range of traded prices to 23 Oct 2026
₹233.40Low, 23 Oct 2026₹340.00High, 30 Jul 2026
Market cap
₹7,999 Cr604th largest listed
P/E
Earlier quarters restated in the year
P/B
5.2
Dividend yield
0.08%
ROCE
12.2%
Debt to equity
0.33
Volume, NSE
2,98,24550.6% delivered

3 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Jupiter Life Line Hospitals annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹1,500 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue1,500
  2. Materials and goods−287
  3. Employee costs−256
  4. Other expenses−613
  5. Operating profit343
  6. Depreciation−88
  7. Other income+42
  8. One-off items0.0
  9. Finance costs−33
  10. Profit before tax265
  11. Tax−66
  12. Net profit199

What the company owns

  • Plant, investments and other assets₹1,725 Cr
  • Current investments₹486 Cr
  • Receivables₹76 Cr
  • Cash and bank₹58 Cr
  • Inventory₹38 Cr

What pays for it: net worth and liabilities

  • Net worth₹1,544 Cr
  • Borrowings₹509 Cr
  • Other liabilities₹235 Cr
  • Owed to suppliers₹96 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Jupiter Life Line Hospitals quarterly results

₹ croreMar 2024Filed 13 MayMar 2025Filed 10 JunMar 2026Filed 15 May
Revenue from operations1,0701,2621,500
8319651,157
Materials and goods bought189230287
Employee costs190214256
Other expenses452520613
Operating profit before depreciation238297343
Operating margin22.3%23.5%22.9%
Materials, % of revenue17.7%18.2%19.2%
Employee costs, % of revenue17.8%17.0%17.1%
Other expenses, % of revenue42.3%41.2%40.9%
Depreciation and amortisation425788
Operating profit after depreciation196240256
Other income262942
Finance costs261133
One-off items000
Profit before tax195258265
196466
177194199
Other comprehensive income1−1−4
Total comprehensive income178192195
Net margin16.5%15.3%13.3%

Balance sheet

Consolidated, ₹ crore, at 31 March. The last column is the half year to Sep 2026, after the latest full year: the balance sheet at its end.

₹ croreMar 2024Filed 13 MayMar 2025Filed 10 JunMar 2026Filed 15 MaySep 2026Half yearFiled 23 Oct
1,1691,3561,5441,631
1,1691,3561,5441,630
Share capital66666666
Reserves1,1031,2911,4791,565
Belonging to outside owners of subsidiaries0000
0326509589
106152227246
7396612683
Total assets1,2811,9052,3832,560
8721,2181,6981,945
410687685615
Net debt−318−277−35157
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only.

Cash flow

Consolidated, ₹ crore, years to March. The last column is the half year to Sep 2026, after the latest full year: the cash flow over its six months.

₹ croreMar 2024Filed 13 MayMar 2025Filed 10 JunMar 2026Filed 15 MaySep 2026Half yearFiled 23 Oct
115253268136
164321332168
−8122−29−23
Receivables−1414−34−46
Inventories−2−3−123
Payables−8727−31
Other working capital−563−951
Tax paid−50−67−64−32
Capital spending85321502293
Free cash flow29−67−234−157
−76−209−442−176
12830113628
Dividends paid6777
Shares bought back0000
Shares issued633000
Net change in cash167345−38−12
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Consolidated, ₹ per share, years to March.Jupiter Life Line Hospitals dividend history

₹ per shareMar 2024Filed 13 MayMar 2025Filed 10 JunMar 2026Filed 15 May
₹5.73₹5.89₹5.92
As stated that year₹28.65₹29.47₹29.59
₹5.73₹5.89₹5.92
₹0.20₹0.20₹0.20
₹35.65₹41.37₹47.10
Dividend payout3.7%3.4%3.3%
Shareholder yield−8.0%0.1%0.1%
Market cap at the year end (₹ crore)7,84510,4688,400
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from.
RatioMar 2024Filed 13 MayMar 2025Filed 10 JunMar 2026Filed 15 May
Revenue growth–18.0%18.9%
Operating profit growth–24.5%15.7%
Net profit growth–9.6%2.9%
Earnings per share growth–2.9%0.4%
15.1%15.3%13.7%
–0.2 pts−1.6 pts
From the net margin–−1.1 pts−2.1 pts
From asset turnover–−0.7 pts−1.5 pts
From borrowing–2.0 pts2.0 pts
Return on capital employed16.8%14.2%12.5%
Cash conversion64.8%130.9%134.5%
Interest cover7.422.77.8
Debt to equity0.000.240.33
Receivable days201218
Inventory days413849
Payable days120163121
Cash conversion cycle, days−59−113−54
Working capital days−5−19−19
Asset turnover0.830.790.70
Assets per rupee of net worth1.101.261.48
Sales per rupee of plant1.491.301.09
Capital spending to depreciation2.015.635.73
Plant being built, % of plant in use10.3%19.0%9.4%

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
9.3%
Cash from operations against operating profit
78.0%
Measure3 years
Return on equity, average14.7%
Return on capital employed, average14.5%
Operating margin, average22.9%
Net margin, average15.0%
Asset turnover, average0.78
Cash conversion cycle, days, average−75
Interest cover, average12.7
Debt to equity, average0.19

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore3 yearsLatest year
Cash from operations636268
Cash from investing−726−442
Cash from financing565136
Capital spending908502
Dividends paid197
Shares bought back00
Shares issued for cash6330
Borrowings raised596186
Borrowings repaid5603

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––4
Altman Z-scorePublished threshold 1.8144.7013.868.15
Beneish M-scorePublished threshold −1.78–−3.45−2.03
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–9.3417.41
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––1.12
Receivables growth less revenue growthOur threshold 0 percentage points–−44.7461.44
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–−8.5634.27
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–0.440.60
Assets under construction, years of additionsOur threshold 2 years of additions–0.590.26
Effective tax ratePublished threshold 17.16 per cent9.6224.9124.97
Tax charged less tax paid, % of profitOur threshold 10 percentage points−15.80−1.260.90
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
10 Mar 2026ICRA Limited (opens in a new tab)Interchangeable limits-Bank guarantee[ICRA]A1+Review, Re-affirm58
10 Mar 2026ICRA Limited (opens in a new tab)Interchangeable limits-Letter of credit[ICRA]A1+Review, Re-affirm50
10 Mar 2026ICRA Limited (opens in a new tab)Fund-based-Overdraft[ICRA]A1+Review, Re-affirm60
10 Mar 2026ICRA Limited (opens in a new tab)Interchangeable limits-Letter of credit[ICRA]AA-Review, UpgradeStable200
10 Mar 2026ICRA Limited (opens in a new tab)Fund-based-Term loan[ICRA]AA-Review, UpgradeStable350
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.